DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main from 13F filings

Historical chart of DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 1.0M 1.04

More positions owned by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Astrazeneca Ord (AZN)
Broadcom (AVGO)
Totalenergies Se Act (TTE)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A Call Option (META)
Wal-Mart Stores (WMT)
Welltower Inc Com reit (WELL)
Alphabet Cap Stk Cl C (GOOG)
Bank of America Corporation (BAC)
Applied Materials (AMAT)

View all positions for DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1